Nishadil
Signup Signin
Delhi | 25°C (windy)
Bristol Myers Squibb's Abecma Delivers Breakthrough Results in Multiple Myeloma Study

Bristol Myers Squibb's Abecma Delivers Breakthrough Results in Multiple Myeloma Study
From Relapse to Remarkable Recovery: How AI and CAR T-Cell Therapy Gave a Farmer a New Lease on Life

From Relapse to Remarkable Recovery: How AI and CAR T-Cell Therapy Gave a Farmer a New Lease on Life
Cero Therapeutics' Cancer Drug Gets FDA Fast Track, Yet Stock Plummets: Unpacking the Market's Paradox

Cero Therapeutics' Cancer Drug Gets FDA Fast Track, Yet Stock Plummets: Unpacking the Market's Paradox
Cell Therapy Manufacturing Market Set to Skyrocket to $18.89 Billion by 2034, Fueled by Chronic Disease Epidemic and Biotech Advancements

Cell Therapy Manufacturing Market Set to Skyrocket to $18.89 Billion by 2034, Fueled by Chronic Disease Epidemic and Biotech Advancements
Sarcoma's Silent Threat: Unveiling Hope Through Early Detection and Revolutionary Therapies

Sarcoma's Silent Threat: Unveiling Hope Through Early Detection and Revolutionary Therapies
A New Dawn in Oncology: Kite Pharma's $350 Million Acquisition of Interius Biotherapeutics Set to Revolutionize CAR T-Cell Therapy

A New Dawn in Oncology: Kite Pharma's $350 Million Acquisition of Interius Biotherapeutics Set to Revolutionize CAR T-Cell Therapy
CARsgen Therapeutics Unveils Stellar 2025 Interim Achievements: A Deep Dive into Innovation and Growth

CARsgen Therapeutics Unveils Stellar 2025 Interim Achievements: A Deep Dive into Innovation and Growth
Load more..